OncoSenX
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
All edits by James Smith
Edits on 30 Apr, 2019
James Smith
Edits made to:
Article (+5/-5 characters)
Article
The delivery system uses a patented lipid nanoparticle (LNP) as a transfection agent to deliver the non-integrating DNA plasmid into cancer cells. Non-Human Primate Studies began in August, 2017 by RxGenRxGen which showed no visible toxicity at doses ten times the normal human dose, but full analysis is yet to be completed.
Find more companies like OncoSenX
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.